SUZANNE GAVRILOVIC: Open Payments
NPI 1396380044 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 89 payments from 16 companies in 2025. Trend: 2023 $1,042 · 2024 $1,638 · 2025 $2,957
Food & beverage: $2,764Education: $194
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $572 |
| Galderma Laboratories, L.P. | 4 | $465 |
| ABBVIE INC. | 17 | $445 |
| Mallinckrodt Hospital Products Inc. | 8 | $272 |
| Amgen Inc. | 7 | $244 |
| Regeneron Healthcare Solutions, Inc. | 7 | $215 |
| UCB, Inc. | 3 | $201 |
| Incyte Corporation | 1 | $122 |
| GENZYME CORPORATION | 4 | $91 |
| PFIZER INC. | 3 | $84 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, DUPIXENT, ACTHAR, OTEZLA, Bimzelx, Opzelura.
Industry payments across FL — which companies pay providers there.
